The road to chromatin - Nuclear entry of retroviruses

Nature Reviews Microbiology

Volumn 5, Issue 3, 2007, Pages 187-196

  Suzuki, Youichi ^a   Craigie, Robert ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; INTEGRASE; KARYOPHERIN; LENS EPITHELIUM DERIVED GROWTH FACTOR; PROTEIN P21; PROTEIN P75; VIRUS DNA; VIRUS NUCLEOPROTEIN; VIRUS PROTEIN; VPR PROTEIN;

CELL CYCLE PROGRESSION; CELL NUCLEUS; CELL TRANSPORT; CHROMATIN STRUCTURE; DNA STRUCTURE; DNA SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; RETROVIRUS INFECTION; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS REPLICATION;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL CYCLE; CELL NUCLEUS; CHROMATIN; DNA, VIRAL; GENES, VIRAL; HIV-1; MOLONEY MURINE LEUKEMIA VIRUS; RETROVIRIDAE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33847139800     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1579     Document Type: Review

References (163)

1. Coffin, J., Hughes, S. & Varmus, H. Retroviruses (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1997).
2. Goff, S. P. Intracellular trafficking of retroviral genomes during the early phase of infection: Viral exploitation of cellular pathways. J. Gene Med. 3, 517-528 (2001).
3. Whittaker, G. R., Kann, M. & Helenius, A. Viral entry into the nucleus. Annu. Rev. Cell Dev. Biol. 16, 627-651 (2000).
4. Anderson, J. L. & Hope, T. J. Intracellular trafficking of retroviral vectors: Obstacles and advances. Gene Ther. 12, 1667-1678 (2005).
5. Katz, R. A., Greger, J. G. & Skalka, A. M. Effects of cell cycle status on early events in retroviral replication. J. Cell Biochem. 94, 880-889 (2005).
6. Gruenbaum, Y., Margalit, A., Goldman, R. D., Shumaker, D. K. & Wilson, K. L. The nuclear lamina comes of age. Nature Rev. Mol. Cell Biol. 6, 21-31 (2005).
7. Fahrenkrog, B. & Aebi, U. The nuclear pore complex: Nucleocytoplasmic transport and beyond. Nature Rev. Mol. Cell Biol. 4, 757-766 (2003).
8. Roe, T., Reynolds, T. C., Yu, G. & Brown, P. O. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12, 2099-2108 (1993).
9. Weinberg, J. B., Matthews, T. J., Cullen, B. R. & Malim, M. H. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174, 1477-1482 (1991).
10. Fouchier, R. A. & Malim, M. H. Nuclear import of human immunodeficiency virus type-1 preintegration complexes. Adv. Virus Res. 52, 275-299 (1999).
11. Dvorin, J. D. & Malim, M. H. Intracellular trafficking of HIV-1 cores: journey to the center of the cell. Curr. Top. Microbiol. Immunol. 281, 179-208 (2003).
12. Bukrinskaya, A., Brichacek, B., Mann, A. & Stevenson, M. Establishment of a functional human immunodeficiency virus type 1 (HIV-1 reverse transcription complex involves the cytoskeleton. J. Exp. Med. 188, 2113-2125 (1998).
13. Fassati, A. & Goff, S. P. Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. J. Virol. 73, 8919-8125 (1999).
14. Fassati, A. & Goff, S. P. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75, 3626-3635 (2001).
15. Narayan, S. & Young, J. A. Reconstitution of retroviral fusion and uncoating in a cell-free system. Proc. Natl Acad. Sci. USA 101, 7721-7726 (2004).
16. Iordanskiy, S., Berro, R., Altieri, M., Kashanchi, F. & Bukrinsky, M. Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin. Retrovirology 3, 4 (2006).
17. McDonald, D. et al. Visualization of the intracellular behavior of HIV in living cells, J. Cell Biol. 159, 441-452 (2002).
18. Bukrinsky, M. I. et al. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl Acad. Sci. USA 90, 6125-6129 (1993).
19. Miller, M. D., Farnet, C. M. & Bushman, F. D. Human immunodeficiency virus type 1 preintegration complexes: Studies of organization and composition. J. Virol. 71, 5382-5390 (1997).
20. Brown, P. O., Bowerman, B., Varmus, H. E. & Bishop, J. M. Correct integration of retroviral DNA in vitro. Cell 49, 347-356 (1987).
21. Fujiwara, T. & Mizuuchi, K. Retroviral DNA integration: Structure of an integration intermediate. Cell 54, 497-504 (1988).
22. Bowerman, B., Brown, P. O., Bishop, J. M. & Varmus, H. E. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3, 469-478 (1989).
23. Ellison, V., Abrams, H., Roe, T., Lifson, J. & Brown, P. Human immunodeficiency virus integration in a cell-free system. J. Virol. 64, 2711-2715 (1990).
24. Farnet, C. M. & Haseltine, W. A. Integration of human immunodeficiency virus type 1 DNA in vitro. Proc. Natl Acad. Sci. USA 87, 4164-4168 (1990).
25. Lee, M. S. & Craigie, R. Protection of retroviral DNA from autointegration: Involvement of a cellular factor. Proc. Natl Acad. Sci. USA 91, 9823-9827 (1994).
26. Farnet, C. M. & Bushman, F. D. HIV-1 cDNA integration: Requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 88, 483-492 (1997).
27. Li, L. et al. Retroviral cDNA integration: Stimulation by HMG I family proteins. J. Virol. 74, 10965-10974 (2000).
28. Farnet, C. M. & Haseltine, W. A. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65, 1910-1915 (1991).
29. Karageorgos, L., Li, P. & Burrell, C. Characterization of HIV replication complexes early after cell-to-cell infection. AIDS Res. Hum. Retroviruses 9, 817-823 (1993).
30. Gallay, P., Swingler, S., Song, J., Bushman, F. & Trono, D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83, 569-576 (1995).
31. Lee, M. S. & Craigie, R. A previously unidentified host protein protects retroviral DNA from autointegration. Proc. Natl Acad. Sci. USA 95, 1528-1533 (1998).
32. Li, L. et al. Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J. 20, 3272-3281 (2001).
33. Suzuki, Y. & Craigie, R. Regulatory mechanisms by which barrier-to-autointegration factor blocks autointegration and stimulates intermolecular integration of Moloney murine leukemia virus preintegration complexes. J. Virol. 76, 12376-12380 (2002).
34. Lin, C. W. & Engelman, A. The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes. J. Virol. 77, 5030-5036 (2003).
35. Llano, M. et al. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J. Virol. 78, 9524-9537 (2004).
36. Suzuki, Y., Yang, H. & Craigie, R. LAP2α and BAF collaborate to organize the Moloney murine leukemia virus preintegration complex. EMBO J. 23, 4670-4678 (2004).
37. Vandegraaff, N., Devroe, E., Turlure, F., Silver, P. A. & Engelman, A. Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication. Virology 346, 415-426 (2006).
38. Sodeik, B., Ebersold, M. W. & Helenius, A. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 136, 1007-1021 (1997).
39. Ploubidou, A. et al. Vaccinia virus infection disrupts microtubule organization and centrosome function. EMBO J. 19, 3932-3944 (2000).
40. Suomalainen, M., Nakano, M. Y., Boucke, K., Keller, S. & Greber, U. F. Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J. 20, 1310-1319 (2001).
41. Arhel, N. et al. Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes. Nature Methods 3, 817-824 (2006).
42. McDonald, D. The inside track of HIV. Nature Methods 3, 782-783 (2006).
43. Heine, U. I., Demsey A. E., Tucker, R. W. & Bykovsky, A. F. Intracellular type A retrovirus movement associated with an intact microtubule system. J. Gen. Virol. 66, 275-282 (1985).
44. Saib, A., Puvion-Dutilleul, F., Schmid, M., Peries, J. & de The, H. Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J. Virol. 71, 1155-1161 (1997).
45. Rey, O., Canon, J. & Krogstad, P. HIV-1 Gag protein associates with F-actin present in microfilaments. Virology 220, 530-534 (1996).
46. Liu, B. et al. Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. J. Virol. 73, 2901-2908 (1999).
47. Wilk, T., Gowen, B. & Fuller, S. D. Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. J. Virol. 73, 1931-1940 (1999).
48. Kim, W. et al. Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor protein. J. Virol. 72, 6898-6901 (1998).
49. Tang, Y. et al. Cellular motor protein KIF-4 associates with retroviral Gag. J. Virol. 73, 10508-10513 (1999).
50. Petit, C. et al. Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8. J. Cell Sci. 116, 3433-3442 (2003).
51. Harel, J., Rassart, E. & Jolicoeur, P. Cell cycle dependence of synthesis of unintegrated viral DNA in mouse cells newly infected with murine leukemia virus. Virology 110, 202-207 (1981).
52. Miller, D. G., Adam, M. A. & Miller, A. D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell Biol. 10, 4239-4242 (1990).
53. Lewis, P. F. & Emerman, M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68, 510-516 (1994).
54. Hatziioannou, T. & Goff, S. P. Infection of nondividing cells by Rous sarcoma virus. J. Virol. 75, 9526-9531 (2001).
55. Bukrinsky, M. I. et al. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl Acad. Sci. USA 89, 6580-6584 (1992).
56. Lewis, P., Hensel, M. & Emerman, M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11, 3053-3058 (1992).
57. Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267 (1996).
58. Miyake, K., Suzuki, N., Matsuoka, H., Tohyama, T. & Shimada, T. Stable integration of human immunodeficiency virus-based retroviral vectors into the chromosomes of nondividing cells. Hum. Gene Ther. 9, 467-475 (1998).
59. Blankson, J. N., Persaud, D. & Siliciano, R. F. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53, 557-593 (2002).
60. Kaul, M., Garden, G. A. & Lipton, S. A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988-994 (2001).
61. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70, 2581-2585 (1996).
62. Naldini, L., Blomer, U., Gage, F. H., Trono, D. & Verma, I. M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl Acad. Sci. USA 93, 11382-11388 (1996).
63. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283, 682-686 (1999).
64. Zennou, V. et al. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nature Biotechnol. 19, 446-450 (2001).
65. Ailles, L. E. & Naldini, L. HIV-1 -derived lentiviral vectors. Curr. Top. Microbiol. Immunol. 261, 31-52 (2002).
66. Poeschla, E. et al. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors. J. Virol. 72, 6527-6536 (1998).
67. Poeschla, E. M., Wong-Staal, F. & Looney, D. J. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nature Med. 4, 354-357 (1998).
68. Johnston, J. & Power, C. Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: Implications for vector development. J. Virol. 73, 2491-2498 (1999).
69. White, S. M. et al. Lentivirus vectors using human and simian immunodeficiency virus elements. J. Virol. 73, 2832-2840 (1999).
70. Zielske, S. P. & Stevenson, M. Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages. J. Virol. 79, 11541-11546 (2005).
71. Weiss, R. Studies on the loss of growth inhibition in cells infected with Rous sarcoma virus. Int. J. Cancer 6, 333-345 (1970).
72. Humphries, E. H. & Temin, H. M. Cell cycle-dependent activation of Rous sarcoma virus-infected stationary chicken cells: Avian leukosis virus group-specific antigens and ribonucleic acid. J. Virol. 10, 82-87 (1972).
73. Humphries, E. H. & Temin, H. M. Requirement for cell division for initiation of transcription of Rous sarcoma virus RNA. J. Virol. 14, 531-546 (1974).
74. Varmus, H. E., Padgett, T., Heasley, S., Simon, G. & Bishop, J. M. Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell 11, 307-319 (1977).
75. Humphries, E. H., Glover, C. & Reichmann, M. E. Rous sarcoma virus infection of synchronized cells establishes provirus integration during S-phase DNA synthesis prior to cellular division. Proc. Natl Acad. Sci. USA 78, 2601-2605 (1981).
76. Katz, R. A. et al. Transduction of interphase cells by avian sarcoma virus. J. Virol. 76, 5422-5434 (2002).
77. Greger, J. G., Katz, R. A., Taganov, K., Rall, G. F. & Skalka, A. M. Transduction of terminally differentiated neurons by avian sarcoma virus. J. Virol. 78, 4902-4906 (2004).
78. Jarrosson-Wuilleme, L. et al. Transduction of nondividing human macrophages with gammaretrovirus-derived vectors. J. Virol. 80, 1152-1159 (2006).
79. Bieniasz, P. D., Weiss, R. A. & McClure, M. O. Cell cycle dependence of foamy retrovirus infection. J. Virol. 69, 7295-7299 (1995).
80. Parveen, Z. et al. Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells. Nature Biotechnol. 18, 623-629 (2000).
81. Mattaj, I. W. & Englmeier, L. Nucleocytoplasmic transport: The soluble phase. Annu. Rev. Biochem. 67, 265-306 (1998).
82. Nermut, M. V. & Fassati, A. Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes. J. Virol. 77, 8196-8206 (2003).
83. Bukrinsky, M. I. et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365, 666-669 (1993).
84. von Schwedler, U., Kornbluth, R. S. & Trono, D. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl Acad. Sci. USA 91, 6992-6996 (1994).
85. Haffar, O. K. et al. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J. Mol. Biol. 299, 359-368 (2000).
86. Depienne, C. et al. Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses. Exp. Cell Res. 260, 387-395 (2000)
87. Gallay, P., Swingler, S., Aiken, C. & Trono, D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80, 379-388 (1995).
88. Freed, E. O., Englund, G., Maldarelli, F. & Martin, M. A. Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. Cell 88, 171-173 (1997).
89. Freed, E. O., Englund, G. & Martin, M. A. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J. Virol. 69, 3949-3954 (1995).
90. Fouchier, R. A., Meyer, B. E., Simon, J. H., Fischer, U. & Malim, M. H. HIV-1 infection of non-dividing cells: Evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16, 4531-4539 (1997).
91. Reil, H., Bukovsky, A. A., Gelderblom, H. R. & Gottlinger, H. G. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17, 2699-2708 (1998).
92. Cohen, E. A., Dehni, G., Sodroski, J. G. & Haseltine, W. A. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64, 3097-3099 (1990).
93. Paxton, W., Connor, R. I. & Landau, N. R. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 67, 7229-7237 (1993).
94. gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J. Virol. 69, 2759-2764 (1995).
95. gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles. J. Virol. 69, 6873-6879 (1995).
96. Bukrinsky, M. & Adzhubei, A. Viral protein R of HIV-1. Rev. Med. Virol. 9, 39-49 (1999).
97. Lu, Y. L., Spearman, P. & Ratner, L. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67, 6542-6550 (1993).
98. Heinzinger, N. K. et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl Acad. Sci. USA 91, 7311-7315 (1994).
99. Connor, R. I., Chen, B. K., Choe, S. & Landau, N. R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206, 935-944 (1995).
100. Popov, S. et al. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 17, 909-917 (1998).
101. Balliet, J. W. et al. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: Mutational analysis of a primary HIV-1 isolate. Virology 200, 623-631 (1994).
102. Vodicka, M. A., Koepp, D. M., Silver, P. A. & Emerman, M. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12, 175-185 (1998).
103. Kootstra, N. A. & Schuitemaker, H. Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages. Virology 253, 170-180 (1999).
104. Bouyac-Bertoia, M. et al. HIV-1 infection requires a functional integrase NLS. Mol. Cell 7, 1025-1035 (2001).
105. Yamashita, M. & Emerman, M. The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathog. 1, e18 (2005).
106. Jenkins, Y., McEntee, M., Weis, K. & Greene, W. C. Characterization of HIV-1 Vpr nuclear import: Analysis of signals and pathways. J. Cell Biol. 143, 875-885 (1998).
107. Karni, O., Friedler, A., Zakai, N., Gilon, C. & Loyter, A. A peptide derived from the N-terminal region of HIV-1 Vpr promotes nuclear import in permeabilized cells: Elucidation of the NLS region of the Vpr. FEBS Lett. 429, 421-425 (1998).
108. Popov, S., Rexach, M., Ratner, L., Blobel, G. & Bukrinsky, M. Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. J. Biol. Chem. 273, 13347-13352 (1998).
109. de Noronha, C. M. et al. Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. Science 294, 1105-1108 (2001).
110. Scott, E. S. & O'Hare, P. Fate of the inner nuclear membrane protein lamin B receptor and nuclear lamins in herpes simplex virus type 1 infection. J. Virol. 75, 8818-8830 (2001).
111. Gallay, P., Hope, T., Chin, D. & Trono, D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/ karyopherin pathway. Proc. Natl Acad. Sci. USA 94, 9825-9830 (1997).
112. Depienne, C. et al. Characterization of the nuclear import pathway for HIV-1 integrase. J. Biol. Chem. 276, 18102-18107 (2001).
113. Petit, C., Schwartz, O. & Mammano, F. Oligomerization within virions and subcellular localization of human immunodeficiency virus type 1 integrase. J. Virol. 73, 5079-5088 (1999)
114. Pluymers, W., Cherepanov, P., Schols, D., De Clercq, E. & Debyser, Z. Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein. Virology 258, 327-332 (1999)
115. Ikeda, T. et al. Evaluation of the functional involvement of human immunodeficiency virus type 1 integrase in nuclear import of viral cDNA during acute infection. J. Virol. 78, 11563-11573 (2004).
116. Dvorin, J. D. et al. Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import. J. Virol. 76, 12087-12096 (2002).
117. Limon, A. et al. Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import. J. Virol. 76, 10598-10607 (2002).
118. Engelman, A., Englund, G., Orenstein, J. M., Martin, M. A. & Craigie, R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69, 2729-2736 (1995).
119. Masuda, T. Planelles, V. Krogstad, P. & Chen, I. S. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J. Virol. 69, 6687-6696 (1995).
120. Leavitt, A. D., Robles, G., Alesandro, N. & Varmus, H. E. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J. Virol. 70, 721-728 (1996).
121. Petit, C., Schwartz, O. & Mammano, F. The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA. J. Virol. 74, 7119-7126 (2000).
122. Tsurutani, N. et al. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells. J. Virol. 74, 4795-4806 (2000).
123. Devroe, E., Engelman, A. & Silver, P. A. Intracellular transport of human immunodeficiency virus type 1 integrase. J. Cell Sci. 116, 4401-4408 (2003).
124. Maertens, G. et al. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J. Biol. Chem. 278, 33528-33539 (2003).
125. Morris-Vasios, C., Kochan, J. P. & Skalka, A. M. Avian sarcoma-leukosis virus pol-endo proteins expressed independently in mammalian cells accumulate in the nucleus but can be directed to other cellular compartments. J. Virol. 62, 349-353 (1988).
126. Mumm, S. R., Hippenmeyer, P. J. & Grandgenett, D. P. Characterization of a stable eukaryotic cell line expressing the Rous sarcoma virus integrase. Virology 189, 500-510 (1992).
127. Kukolj, G., Jones, K. S. & Skalka, A. M. Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases. J. Virol. 71, 843-847 (1997).
128. Kukolj, G., Katz, R. A. & Skalka, A. M. Characterization of the nuclear localization signal in the avian sarcoma virus integrase. Gene 223, 157-163 (1998).
129. Risco, C., Menendez-Arias, L., Copeland, T. D., Pinto da Silva, P. & Oroszlan, S. Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 cells: Nuclear import of nucleocapsid protein and integrase. J. Cell Sci. 108, 3039-3050 (1995).
130. Yamashita, M. & Emerman, M. Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J. Virol. 78, 5670-5678 (2004).
131. Yamashita, M. & Emerman, M. Retroviral infection of non-dividing cells: old and new perspectives. Virology 344, 88-93 (2006).
132. Yuan, B., Li, X. & Goff, S. P. Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J. 18, 4700-4710 (1999).
133. Zennou, V. et al. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101, 173-85 (2000).
134. Stevenson, M. HIV nuclear import: What's the flap? Nature Med. 6, 626-628 (2000).
135. Charneau, P., Alizon, M. & Clavel, F. A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J. Virol. 66, 2814-2820 (1992).
136. Charneau, P. et al. HIV-1 reverse transcription. A termination step at the center of the genome. J. Mol. Biol. 241, 651-662 (1994).
137. Hungnes, O., Tjotta, E. & Grinde, B. Mutations in the central polypurine tract of HIV-1 result in delayed replication. Virology 190, 440-442 (1992).
138. Follenzi, A., Ailles, L. E., Bakovic, S., Geuna, M. & Naldini, L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nature Genet. 25, 217-222 (2000).
139. Sirven, A. et al. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 96, 4103-4110 (2000).
140. Dardalhon, V. et al. Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. Gene Ther. 8, 190-198 (2001).
141. Limon, A., Nakajima, N., Lu, R., Ghory, H. Z. & Engelman, A. Wild-type levels of nuclear localization and human immunodeficiency virus type 1 replication in the absence of the central DNA flap. J. Virol. 76, 12078-12086 (2002).
142. Arhel, N. J., Souquere-Besse, S. & Charneau, P. Wild-type and central DNA flap defective HIV-1 lentiviral vector genomes: Intracellular visualization at ultrastructural resolution levels. Retrovirology 3, 38 (2006).
143. Arhel, N., Munier, S., Souque, P., Mollier, K., and Charneau, P. Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type. J. Virol. 80, 10262-10269 (2006).
144. De Rijck, J., and Debyser, Z. The central DNA flap of human immunodeficiency virus type 1 is important for viral replication. Biochem. Biophys. Res. Com. 349, 1100-1110 (2006).
145. Gallay, P., Stitt, V., Mundy, C., Oettinger, M. & Trono, D. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70, 1027-1032 (1996).
146. Fouchier, R. A. et al. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J. Virol. 72, 6004-6013 (1998).
147. Ebina, H., Aoki, J., Hatta, S., Yoshida, T. & Koyanagi, Y. Role of Nup98 in nuclear entry of human immunodeficiency virus type 1 cDNA. Microbes Infect. 6, 715-724 (2004).
148. Fassati, A., Gorlich, D., Harrison, I., Zaytseva, L. & Mingot, J. M. Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. EMBO J. 22, 3675-3685 (2003).
149. Zaitseva, L. Myers, R. & Fassati, A. tRNAs promote nuclear import of HIV-1 intranuclear reverse transcription complexes. PLoS Biol. 4, 1689-1706 (2006)
150. Cherepanov, P. et al. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem. 278, 372-381 (2003).
151. Llano, M. Delgado S., Vanegas M. & Poeschla E. M. Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J. Biol. Chem. 279, 55570-55577 (2004).
152. Vanegas, M. et al. Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. J. Cell Sci. 118, 1733-1743 (2005).
153. Maertens, G., Cherepanov, P., Debyser, Z., Engelborghs, Y. & Engelman, A. Identification and characterization of a functional nuclear localization signal in the HIV-1 integrase interactor LEDGF/p75. J. Biol. Chem. 279, 33421-33429 (2004).
154. Busschots, K. et al. The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. J. Biol. Chem. 280, 17841-17847 (2005).
155. Zielske, S. P. & Stevenson, M. Modest but reproducible inhibition of human immunodeficiency virus type 1 infection in macrophages following LEDGFp75 silencing. J. Virol. 80, 7275-7280 (2006).
156. Llano, M. et al. An essential role for LEDGF/p75 in HIV integration. Science 314, 461-464 (2006).
157. Emiliani, S. et al. Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication. J. Biol. Chem. 280, 25517-25523 (2005).
158. Turlure, F., Maertens, G., Rahman, S., Cherepanov, P. & Engelman, A. A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo. Nucleic Acids Res. 34, 1663-1675 (2006).
159. Ciuffi, A. et al. A role for LEDGF/p75 in targeting HIV DNA integration. Nature Med. 11, 1287-1289 (2005).
160. Vandekerckhove, L. et al. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus. J. Virol. 80, 1886-1896 (2006).
161. Jacque, J. M. & Stevenson, M. The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity. Nature 441, 641-645 (2006).
162. Shun, M. C., Daigle, J. E., Vandegraaff, N. & Engelman, A. Wild-type levels of human immunodeficiency virus type 1 infectivity in the absence of cellular emerin protein. J. Virol. 81, 166-172 (2006).
163. Anonymous. Whither RNAi? Nature Cell Biol. 5, 489-490 (2003).